Statins for primary prevention of cardiovascular disease have uncertain benefits, particularly in low-risk individuals, highlighting a need for better data to guide shared decision making.
Do statins provide clear benefits for primary prevention in people at low risk of cardiovascular disease?
This paper highlights the ongoing uncertainties regarding statin use for primary prevention in low-risk individuals and emphasizes the importance of shared decision making.
Absolute Event Rate: 0% vs 0%
Paula Byrne, John Cullinan, and Susan Smith explain the uncertainties about the benefits of statins, particularly in people at low risk of cardiovascular disease, and the need for better data to help shared decision making
Byrne et al. (Wed,) reported a other. Statins for primary prevention of cardiovascular disease have uncertain benefits, particularly in low-risk individuals, highlighting a need for better data to guide shared decision making.